Bruker (BRKR) Divestments (2013 - 2014)

Bruker (BRKR) posted Divestments of $12.5 million for Q4 2014, up 3.31% on a QoQ basis from $12.1 million in Q3 2014.

Bruker (BRKR) Divestments (2013 - 2014) Analysis & Trends

Bruker's Divestments history runs 2 years deep, the most recent figure standing at $12.5 million for Q4 2014.

Quarterly Divestments changed N/A year-over-year to $12.5 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $25.3 million (up 4960.0% YoY) and the FY2015 annual result came in at $200000.0, down 99.21% from the prior year.
Divestments was $12.5 million for Q4 2014 at Bruker, up from $12.1 million in the prior quarter.
Across five years, Divestments topped out at $12.5 million in Q4 2014 and bottomed at $500000.0 in Q1 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	-
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	9.37 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Bruker	9.46 Bn	9.50 Bn	379.80 Mn	-

Download Data